COPOLYMER 1
Teva Pharmaceutical Industries Ltd.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77093265 |
| Registration Number | 3377290 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Howard J. Shire, Esq. |
| Attorney Name | Howard J. Shire, Esq. |
| Attorney Docket Number | 10988/ |
| Law Office Assigned | L40 |
| Employee Name | MACFARLANE, JAMES W |
Timeline
| 2007-01-29 | Application Filed |
| 2007-11-20 | Published for Opposition |
| 2008-02-05 | Location: PUBLICATION AND ISSUE SECTION |
| 2008-02-05 | Trademark Registered |
| 2014-09-12 | Cancelled |
| 2014-09-12 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Teva Pharmaceutical Industries Ltd. |
| Address | Science Based Industries Campus Har Hotzvim, P.O. Box 1142 Jerusalem IL 91010 |
| Legal Entity Type | Corporation |
| Legal Entity State | IL |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| D10000 | "COPOLYMER" |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2007-02-01 | 1 NWAP I:Incoming Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2007-02-02 | 2 PARI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2007-03-02 | 3 ALIE A:Allowance for Publication |
| APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2007-03-02 | 4 AMPX O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2007-05-16 | 5 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 2007-05-23 | 6 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2007-05-23 | 7 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2007-05-23 | 8 GNRT F:First Action |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2007-10-11 | 9 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2007-10-12 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2007-10-12 | 11 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2007-10-16 | 12 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2007-10-16 | 13 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2007-10-31 | 14 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2007-11-20 | 15 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2008-02-05 | 16 R.PR A:Allowance for Publication |
| CANCELLED SEC. 8 (6-YR) | 2014-09-12 | 17 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 COPOLYMER 1 90615904 not registered Live/Pending |
Teva Pharmaceutical Industries Ltd. 2021-03-31 |
 COPOLYMER 1 86233983 4722469 Live/Registered |
Teva Pharmaceutical Industries Ltd. 2014-03-27 |
 COPOLYMER 1 77093265 3377290 Dead/Cancelled |
Teva Pharmaceutical Industries Ltd. 2007-01-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 